CORC

浏览/检索结果: 共25条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
MEDICAL THERAPY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: AN INDIRECT TREATMENT COMPARISON OF MACITENTAN AND RIOCIGUAT 期刊论文
2019, 卷号: 22, 页码: S335-S335
作者:  Di Scala, L.;  Howard, L. S.;  Jing, Z. C.;  Lin, X.;  Mayer, E.
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Synthesis and biological evaluation of pyrazolo[3,4-b]pyridine-3-yl pyrimidine derivatives as sGC stimulators for the treatment of pulmonary hypertension 期刊论文
2019, 卷号: 173, 页码: 107-116
作者:  Li, Liang;  Zhang, Wenpeng;  Lin, Feng;  Lu, Xinqiang;  Chen, Wei
收藏  |  浏览/下载:14/0  |  提交时间:2020/01/03
Spectroscopic methodologies and molecular docking studies on the interaction of the soluble guanylate cyclase stimulator riociguat with human serum albumin 期刊论文
BIOSCIENCE TRENDS, 2018, 卷号: 12, 期号: 4, 页码: 369-374
作者:  Ma, Rui;  Li, Zhenyu;  Di, Xiaxia;  Guo, Dongxiao;  Ji, Jianbo
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2 期刊论文
2017, 卷号: 76, 期号: 2, 页码: 422-426
作者:  Humbert, Marc;  Coghlan, J. Gerry;  Ghofrani, Hossein-Ardeschir;  Grimminger, Friedrich;  He, Jian-Guo
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/03
Comparison of hemodynamic parameters in treatment-naive and pre-treated patients with pulmonary arterial hypertension in the randomized phase III PATENT-1 study 期刊论文
2017, 卷号: 36, 期号: 5, 页码: 509-519
作者:  Galiè Nazzareno;  Grimminger Friedrich;  Grünig Ekkehard;  Hoeper Marius M;  Humbert Marc
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension 期刊论文
2017, 卷号: 11, 页码: 1195-1207
作者:  Lian Tian-Yu;  Jiang Xin;  Jing Zhi-Cheng
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/04
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison 期刊论文
HEART ASIA, 2016, 卷号: 8, 期号: 1
作者:  Wang, Chen;  Jing, Zhi-Cheng;  Huang, Yi-Gao;  Zhou, Da-Xin;  Liu, Zhi-Hong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/13
Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial 期刊论文
2016, 卷号: 4, 期号: 5, 页码: 361-371
作者:  Ghofrani, Hossein-Ardeschir;  Grimminger, Friedrich;  Gruenig, Ekkehard;  Huang, Yigao;  Jansa, Pavel
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison 期刊论文
2016, 卷号: 8, 期号: 1, 页码: 74-82
作者:  Wang Chen;  Jing Zhi-Cheng;  Huang Yi-Gao;  Zhou Da-Xin;  Liu Zhi-Hong
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
Reduction in NT-proBNP and its correlation with survival in patients with PAH treated with riociguat: 2-year results from the PATENT-2 long-term extension study 会议论文
作者:  Hoeper, M. M.;  Galie, N.;  Ghofrani, H. -A.;  He, J.;  Huang, Y.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/13


©版权所有 ©2017 CSpace - Powered by CSpace